Picture of VectivBio Holding AG logo

VECT VectivBio Holding AG Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid Cap

Annual cashflow statement for VectivBio Holding AG, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS20-F20-F
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinal
Net Income/Starting Line-23.5-59.9-87-93.7
Depreciation
Non-Cash Items3.4619.11827.5
Other Non-Cash Items
Changes in Working Capital4.972.39-3.399.77
Change in Accounts Receivable
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-14.9-38.2-72.1-56.3
Capital Expenditures-0.056-0.093-0.057-0.074
Purchase of Fixed Assets
Other Investing Cash Flow Items0.0110.024-6.620
Acquisition of Business
Other Investing Cash Flow
Cash from Investing Activities-0.045-0.069-6.67-0.074
Financing Cash Flow Items0.48-1.33-12.7-13.8
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities32.856.6141175
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash17.720.462.5119